Spain's clinical pathology sector rails against Madrid diagnostics outsourcing
This article was originally published in Clinica
Spain's clinical pathology industry has rallied against plans by the Madrid regional government to outsource the bulk of the region's laboratory services, claiming that the cost-containment drive will radically weaken its provision of care. The plans are part of a hospital modernisation programme involving the construction of 11 new hospitals, most of which are due to open "within the next few months".
You may also be interested in...
UK start-up Iceni Diagnostics has secured funding to develop its test for the live, intact SARS-CoV-2 virus and the UK government is evaluating a lateral flow device based on the technology for testing saliva samples as part of efforts to step up rapid testing in the country. See what Iceni’s CEO Rob Field said about it here.
The run-away US FDA advisory committee review of Biogen’s Alzheimer’s candidate was highly unusual. But like most things at the agency, not entirely unprecedented.
Trump Administration’s attempt to eliminate rebates in the US Medicare outpatient drug benefit program is the easiest and most certain item among the 11th hour pricing policy changes for the incoming Biden Administration to undo. But it still had a major impact on the dynamics of the drug pricing debate.